We use cookies for a better user experience. Read our Privacy Policy

I Agree

Women's Health Market

Women’s Health Market (Treatment Type - Hormonal Treatment (Estrogen Therapy, Progestin Therapy, Combination Therapy, Thyroid Replacement Therapy, Parathyroid Hormone Therapy, and Others) and Non-Hormonal Treatment (Targeted Therapy Drugs, Antibiotics, Bisphosphonates, and Others); Disease Indication - Cancer (Breast Cancer, Cervical Cancer, Ovarian Cancer), Hypothyroidism, Post-Menopausal Syndrome, Osteoporosis, Contraceptive, Uterine Fibroid, Urinary Tract Infection, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

As a result of both gender-related and biological differences, being a woman or a man comes with a considerable impact on health. The health of a girl and woman has always been of particular concern as in several societies women are disadvantaged by the discriminations that are rooted deep into the socio-cultural factors. Such factors create a mindset that considers women’s health insignificant and renders them vulnerable to various diseases. A case in point is girls and women are more vulnerable to HIV/AIDS than men. However, there has been an increasing concern for women’s health from global agencies like World Health Organizations and with the developed nations formulating policies to protect the health of women. This factor is likely to work in favor of the global women’s health market over the period of forecast, from 2017 to 2025.

womens health market

Some socio-cultural factors holding women back from being benefitted from various quality health services and attaining good health include the following:

  • unequal power relationships shared between women and men in all spheres of life;
  • exclusive emphasis on the reproductive role of women
  • social norms discouraging paid employment opportunities and less or no education
  • actual and potential experience of emotional, sexual, and physical violence
  • poverty has been an important obstacle to attain positive health outcomes for both women and men and women. However, poverty tends to bestow women with heavier burden on women. For instance, use of unsafe cooking fuels, malnutrition affects mostly women as opposed to men.

The global women’s health market is likely to be adversely impacted by the ongoing outbreak of coronavirus across the globe. While the health of women, particularly in countries with a poor record in violence against women and health of women, continue to overlook the health-related needs of women, particularly working women who continue to work from home and do household chores at the same time. Several programs promoting health of women in both rural and urban areas have come to standstill. However, once tings return to normal, it is expected that there will renewed activities pertaining to promotion of women’s health, which is likely to bolster growth of the global women’s health market in the years to come.

Some of the leading firms in the global women’s health market comprise Apothecus Pharmaceutical Corporation, Ferring Pharmaceuticals, Bristol Myers Squibb Company, F. Hoffmann-La Roche Ltd, Lupin Pharmaceuticals, Inc., and Eli Lilly and Company. These companies are making use of various business strategies such as regional expansion, research and development activities for new products, and merger and acquisitions.

Rising Government Initiatives and Awareness to Shoot Up Demand in the Market

There has been a rise in the population of elderly women, i.e. women who are aged above 60 years, introduction of novel treatments and medicines for women, and augmented adoption of unhealthy lifestyle. These factors play significant role in boosting the global women’s health market over the tenure of assessment. In addition to that, favorable government policies, such as Indira Gandhi Matritva Sahyog Yojana in India to monitor the health of a mother, have been introduced to better the condition of women’s health. Government schemes are also aimed at raising the level of awareness about the health of women. Prevalence of such government schemes are likely to work in favor of the growth of the global women’s health market in the years to come.

Women are more vulnerable to diseases like obesity, depression, menstrual health-related disorders, anemia, osteoarthritis, and osteoporosis. There has been wide prevalence of these conditions amongst women and the incidences are rising with many of these conditions beginning quite early, such as osteoarthritis affecting women as young as 30 years. Rising prevalence of these medical conditions is likely to augur well for the global women’s health market for the period of analysis, from 2017 to 2025.

According to the findings of International Osteoporosis Foundation (IOF), a nongovernmental organization based out of Switzerland, incidences of osteoporosis amongst women is likely to reach a figure of 680 million by 2050. IOF is tasked with the treatment, diagnosis, and prevention of osteoporosis across the globe. Besides, mental illnesses, cardiovascular diseases, and breast cancer is likely to substantially add to the burden of non-communicable diseases amongst women. Most women are likely to undergo menopause after the age of 50, which creates hormonal changes and leave an undesirable impact of the quality of life of women. Many of the menopausal women experience hot flashes. The Society of Obstetricians and Gynecologists of Canada (SOGC), national medical society in Canada, presented an estimation that indicates at around 80.0% of women will suffer from at one of the side effects of menopause, which could be irritability or lack or interrupted sleep, and mood swings.

In addition to that, there have been changes in the dietary habits of women as well. More women have taken up consumption of alcohol and smoking, stress at work and home, frequent eating out and consumption of ready to eat food items have all contributed toward the deterioration of health of women. Change in lifestyle habits have caused hormonal imbalance and fertility issues in women, which is likely to support expansion of the global women’s health market in the enar future. These factors are estimated to promote growth of the global women’s health market in the years to come. Polycystic ovarian syndrome (PCOS), endometriosis, and ovulation problems are some of the major problems affecting the health of women.

Driven by the US, North America to Present Lucrative Growth Opportunities

It is estimated that North America, driven by the US, is likely to remain at the forefront of the growth of the global women’s health market over the tenure of assessment, from 2017 to 2025. Increased prevalence of women’s health therapeutics, thanks to the high investment made by both government and private agencies for drug research. These research and development activities have led to the invention of several advanced and sophisticated treatments for women, which is likely to support growth of the women’s health market in North America. In addition there has an increased focus on cancer care for women, which is likely to drive the market in the region. Presence of leading biotechnology and pharmaceutical firms in the region is another growth factor for the women’s health market in the region.

With the presence of a large untapped market, rise in government initiatives, and increasing awareness about the health of women are likely to offer rapid growth opportunities for the women’s health market in Asia Pacific in the years to come.

The global women’s health market is segmented as given below:

Treatment Type

  • Hormonal Treatment
    • Estrogen Therapy
    • Progestin Therapy
    • Combination Therapy
    • Thyroid Replacement Therapy
    • Parathyroid Hormone Therapy
    • Others
  • Non-Hormonal Treatment
    • Targeted Therapy Drugs
    • Antibiotics
    • Bisphosphonates
    • Others

Disease Indication

  • Cancer
    • Breast Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Hypothyroidism
  • Post-Menopausal Syndrome
  • Osteoporosis
  • Contraceptive
  • Uterine Fibroid
  • Urinary Tract Infection
  • Others

Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia and New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of MEA
Women's Health Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

1. Preface 
     1.1. Report Scope and Market Segmentation 
     1.2. Research Highlights

2. Assumptions and Research Methodology 
     2.1. Assumptions
     2.2. Acronyms Used
     2.3. Research Methodology

3. Executive Summary
     3.1. Global Women’s Health Market Snapshot

4. Market Overview
     4.1. Market Overview
     4.2. Market Opportunity Map 
     4.3. Key Industry Events
     4.4. Global Women’s Health Market Size (US$ Mn) Forecast, 2015–2025
     4.5. Global Women’s Health Market Outlook
     4.6. Pipeline Analysis
     4.7. Key Trends
     4.8. Government Initiatives/Key Investments Assessment

5. Market Dynamics
     5.1. Drivers and Restraints Snapshot Analysis
     5.2. Drivers
     5.3. Restraints
     5.4. Opportunities

6. Global Women’s Health Market Analysis, by Treatment Type
     6.1. Introduction
     6.2. Key Insights
     6.3. Global Women’s Health Market Value Share Analysis, by Treatment Type
     6.4. Global Women’s Health Market Forecast, by Treatment Type
             6.4.1. Hormonal
                     6.4.1.1. Estrogen
                     6.4.1.2. Progestin
                     6.4.1.3. Combination
                     6.4.1.4. Parathyroid
                     6.4.1.5. Thyroid
                     6.4.1.6. Others
             6.4.2. Non-Hormonal
                     6.4.2.1. Targeted Drugs
                     6.4.2.2. Antibiotics
                     6.4.2.3. Biphosphonates
                     6.4.2.4. Others
     6.5. Global Women’s Health Market Attractiveness Analysis, by Treatment Type
     6.6. Key Trends

7. Global Women’s Health Market Analysis, by Disease Indication
     7.1. Introduction
     7.2. Key Insights
     7.3. Global Women’s Health Market Value Share Analysis, by Treatment Type
     7.4. Global Women’s Health Market Forecast, by Treatment Type
             7.4.1. Cancer
                     7.4.1.1. Breast Cancer
                     7.4.1.2. Cervical Cancer
                     7.4.1.3. Ovarian Cancer
             7.4.2. Hypothyroidism
             7.4.3. Menopause
             7.4.4. Osteoporosis
             7.4.5. Contraceptive
             7.4.6. Uterine Fibroid
             7.4.7. Urinary Tract Infection
     7.5. Global Women’s Health Market Attractiveness Analysis, by Treatment Type
     7.6. Key Trends

8. Global Women’s Health Market Analysis, by Region
     8.1. Global Women’s Health Market Value Share Analysis, by Region 
     8.2. Global Women’s Health Market Forecast, by Region, 2015–2025 
             8.2.1. North America
             8.2.2. Europe
             8.2.3. Asia Pacific
             8.2.4. Latin America
             8.2.5. Middle East & Africa

9. North America Women’s Health Market Analysis
     9.1. North America Women’s Health Market Overview
     9.2. North America Women’s Health Market Value Share Analysis, by Treatment Type
     9.3. North America Women’s Health Market Value Share Analysis, by Disease Indication
     9.4. North America Women’s Health Market Value Share Analysis, by Country
     9.5. North America Women’s Health Market Forecast, by Treatment Type
             9.5.1. Hormonal
                     9.5.1.1. Estrogen
                     9.5.1.2. Progestin
                     9.5.1.3. Combination
                     9.5.1.4. Parathyroid
                     9.5.1.5. Thyroid
                     9.5.1.6. Others
             9.5.2. Non-Hormonal
                     9.5.2.1. Targeted Drugs
                     9.5.2.2. Antibiotics
                     9.5.2.3. Biphosphonates
                     9.5.2.4. Others
     9.6. North America Women’s Health Market Forecast, by Disease Indication
             9.6.1. Cancer
                     9.6.1.1. Breast Cancer
                     9.6.1.2. Cervical Cancer
                     9.6.1.3. Ovarian Cancer
             9.6.2. Hypothyroidism
             9.6.3. Menopause
             9.6.4. Osteoporosis
             9.6.5. Contraceptive
             9.6.6. Uterine Fibroid
             9.6.7. Urinary Tract Infection
     9.7. North America Women’s Health Market Forecast, by Country
             9.7.1. United States
             9.7.2. Canada
     9.8. North America Women’s Health Market Attractiveness Analysis, 
             9.8.1. By Treatment Type 
             9.8.2.  By Disease Indication 
             9.8.3.  By Country
     9.9. North America – Key Trends

10. Europe Women’s Health Market Analysis
     10.1. Europe Women’s Health Market Overview
     10.2. Europe Women’s Health Market Value Share Analysis, by Treatment Type
     10.3. Europe Women’s Health Market Value Share Analysis, by Disease Indication
     10.4. Europe Women’s Health Market Value Share Analysis, by Country
     10.5. Europe Women’s Health Market Forecast, by Treatment Type
             10.5.1. Hormonal
                     10.5.1.1. Estrogen
                     10.5.1.2. Progestin
                     10.5.1.3. Combination
                     10.5.1.4. Parathyroid
                     10.5.1.5. Thyroid
                     10.5.1.6. Others
             10.5.2. Non-Hormonal
                     10.5.2.1. Targeted Drugs
                     10.5.2.2. Antibiotics
                     10.5.2.3. Biphosphonates
                     10.5.2.4. Others
     10.6. Europe Women’s Health Market Forecast, by Disease Indication
             10.6.1. Cancer
                     10.6.1.1. Breast Cancer
                     10.6.1.2. Cervical Cancer
                     10.6.1.3. Ovarian Cancer
             10.6.2. Hypothyroidism
             10.6.3. Menopause
             10.6.4. Osteoporosis
             10.6.5. Contraceptive
             10.6.6. Uterine Fibroid
             10.6.7. Urinary Tract Infection
     10.7. Europe Women’s Health Market Forecast, by Country / Sub-region
             10.7.1. UK
             10.7.2. Germany
             10.7.3. France
             10.7.4. Italy
             10.7.5. Spain
             10.7.6. Rest of Europe
     10.8. Europe Women’s Health Market Attractiveness Analysis 
             10.8.1. By Treatment Type
             10.8.2. By Disease Indication 
             10.8.3. By Country / Sub-region
     10.9. Europe – Key Trends

11. Asia Pacific Women’s Health Market Analysis
     11.1. Asia Pacific Women’s Health Market Overview
     11.2. Asia Pacific Women’s Health Market Value Share Analysis, by Treatment Type
     11.3. Asia Pacific Women’s Health Market Value Share Analysis, by Disease Indication
     11.4. Asia Pacific Women’s Health Market Value Share Analysis, by Country
     11.5. Asia Pacific Women’s Health Market Forecast, by Treatment Type
             11.5.1. Hormonal
                     11.5.1.1. Estrogen
                     11.5.1.2. Progestin
                     11.5.1.3. Combination
                     11.5.1.4. Parathyroid
                     11.5.1.5. Thyroid
                     11.5.1.6. Others
             11.5.2. Non-Hormonal
                     11.5.2.1. Targeted Drugs
                     11.5.2.2. Antibiotics
                     11.5.2.3. Biphosphonates
                     11.5.2.4. Others
     11.6. Asia Pacific Women’s Health Market Forecast, by Disease Indication
             11.6.1. Cancer
                     11.6.1.1. Breast Cancer
                     11.6.1.2. Cervical Cancer
                     11.6.1.3. Ovarian Cancer
             11.6.2. Hypothyroidism
             11.6.3. Menopause
             11.6.4. Osteoporosis
             11.6.5. Contraceptive
             11.6.6. Uterine Fibroid
             11.6.7. Urinary Tract Infection
     11.7. Asia Pacific Women’s Health Market Forecast, by Country / Sub-region
             11.7.1. China
             11.7.2. Japan
             11.7.3. India
             11.7.4. Australia
             11.7.5. Rest of APAC
     11.8. Asia Pacific Women’s Health Market Attractiveness Analysis
             11.8.1. By Treatment Type 
             11.8.2. By Disease Indication 
             11.8.3. By Country / Sub-region
     11.9. Asia Pacific – Key Trends

12. Latin America Women’s Health Market Analysis
     12.1. Latin America Women’s Health Market Overview
     12.2. Latin America Women’s Health Market Value Share Analysis, by Treatment Type
     12.3. Latin America Women’s Health Market Value Share Analysis, by Disease Indication
     12.4. Latin America Women’s Health Market Value Share Analysis, by Country
     12.5. Latin America Women’s Health Market Forecast, by Treatment Type
             12.5.1. Hormonal
                     12.5.1.1. Estrogen
                     12.5.1.2. Progestin
                     12.5.1.3. Combination
                     12.5.1.4. Parathyroid
                     12.5.1.5. Thyroid
                     12.5.1.6. Others
             12.5.2. Non-Hormonal
                     12.5.2.1. Targeted Drugs
                     12.5.2.2. Antibiotics
                     12.5.2.3. Biphosphonates
                     12.5.2.4. Others
     12.6. Latin America Women’s Health Market Forecast, by Disease Indication
             12.6.1. Cancer
                     12.6.1.1. Breast Cancer
                     12.6.1.2. Cervical Cancer
                     12.6.1.3. Ovarian Cancer
             12.6.2. Hypothyroidism
             12.6.3. Menopause
             12.6.4. Osteoporosis
             12.6.5. Contraceptive
             12.6.6. Uterine Fibroid
             12.6.7. Urinary Tract Infection
     12.7. Latin America Women’s Health Market Forecast, by Country / Sub-region
             12.7.1. Brazil
             12.7.2. Mexico
             12.7.3. Rest of Latin America
     12.8. Latin America Women’s Health Market Attractiveness Analysis
             12.8.1. By Treatment Type
             12.8.2. By Disease Indication
             12.8.3. By Country / Sub-region
     12.9. Latin America – Key Trends

13. Middle East & Africa Women’s Health Market Analysis
     13.1. Middle East & Africa Women’s Health Market Overview
     13.2. Middle East & Africa Women’s Health Market Value Share Analysis, by Treatment Type
     13.3. Middle East & Africa Women’s Health Market Value Share Analysis, by Disease Indication
     13.4. Middle East & Africa Women’s Health Market Value Share Analysis, by Country
     13.5. Middle East & Africa Women’s Health Market Forecast, by Treatment Type
             13.5.1. Hormonal
                     13.5.1.1. Estrogen
                     13.5.1.2. Progestin
                     13.5.1.3. Combination
                     13.5.1.4. Parathyroid
                     13.5.1.5. Thyroid
                     13.5.1.6. Others
             13.5.2. Non-Hormonal
                     13.5.2.1. Targeted Drugs
                     13.5.2.2. Antibiotics
                     13.5.2.3. Biphosphonates
                     13.5.2.4. Others
     13.6. Middle East & Africa Women’s Health Market Forecast, by Disease Indication
             13.6.1. Cancer
                     13.6.1.1. Breast Cancer
                     13.6.1.2. Cervical Cancer
                     13.6.1.3. Ovarian Cancer
             13.6.2. Hypothyroidism
             13.6.3. Menopause
             13.6.4. Osteoporosis
             13.6.5. Contraceptive
             13.6.6. Uterine Fibroid
             13.6.7. Urinary Tract Infection
     13.7. Middle East & Africa Women’s Health Market Forecast, by Country / Sub-region
             13.7.1. GCC Countries
             13.7.2. South Africa
             13.7.3. Rest of Middle East & Africa
     13.8. Middle East & Africa Women’s Health Market Attractiveness Analysis
             13.8.1. By Treatment Type
             13.8.2. By Disease Indication
             13.8.3. By Country / Sub-region
     13.9. Middle East & Africa – Key Trends

14. Competition Landscape
     14.1. Competitive Positioning
     14.2. Competition Matrix
     14.3. Company Profiles
             14.3.1. Eli Lilly and Company 
                     14.3.1.1. Overview (HQ, Employee Strength, Business Segments)
                     14.3.1.2. Financials
                     14.3.1.3. Recent Developments
                     14.3.1.4. Strategy
             14.3.2. Novartis AG
                     14.3.2.1. Overview (HQ, Employee Strength, Business Segments)
                     14.3.2.2. Financials
                     14.3.2.3. Recent Developments
                     14.3.2.4. Strategy
             14.3.3. Pfizer, Inc.
                     14.3.3.1. Overview (HQ, Employee Strength, Business Segments)
                     14.3.3.2. Financials
                     14.3.3.3. Recent Developments
                     14.3.3.4. Strategy
             14.3.4. Merck & Co., Inc.
                     14.3.4.1. Overview (HQ, Employee Strength, Business Segments)
                     14.3.4.2. Financials
                     14.3.4.3. Recent Developments
                     14.3.4.4. Strategy
             14.3.5. Novo Nordisk A/S 
                     14.3.5.1. Overview (HQ, Employee Strength, Business Segments)
                     14.3.5.2. Financials
                     14.3.5.3. Recent Developments
                     14.3.5.4. Strategy
             14.3.6. Amgen Inc. 
                     14.3.6.1. Overview (HQ, Employee Strength, Business Segments)
                     14.3.6.2. Financials
                     14.3.6.3. Recent Developments
                     14.3.6.4. Strategy
             14.3.7. AstraZeneca 
                     14.3.7.1. Overview (HQ, Employee Strength, Business Segments)
                     14.3.7.2. Financials
                     14.3.7.3. Recent Developments
                     14.3.7.4. Strategy
             14.3.8. F. Hoffmann-La Roche Ltd.
                     14.3.8.1. Overview (HQ, Employee Strength, Business Segments)
                     14.3.8.2. Financials
                     14.3.8.3. Recent Developments
                     14.3.8.4. Strategy
             14.3.9. Sanofi
                     14.3.9.1. Overview (HQ, Employee Strength, Business Segments)
                     14.3.9.2. Financials
                     14.3.9.3. Recent Developments
                     14.3.9.4. Strategy
             14.3.10. Allergan Plc
                     14.3.10.1. Overview (HQ, Employee Strength, Business Segments)
                     14.3.10.2. Financials
                     14.3.10.3. Recent Developments
                     14.3.10.4. Strategy
             14.3.11. GlaxoSmithKline plc
                     14.3.11.1. Overview (HQ, Employee Strength, Business Segments)
                     14.3.11.2. Financials
                     14.3.11.3. Recent Developments
                     14.3.11.4. Strategy
             14.3.12. Lupin Pharmaceuticals, Inc.
                     14.3.12.1. Overview (HQ, Employee Strength, Business Segments)
                     14.3.12.2. Financials
                     14.3.12.3. Recent Developments
                     14.3.12.4. Strategy

List of Tables

TABLE 1 Global Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
TABLE 2 Global Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type – Hormonal Treatment, 2015–2025
TABLE 3 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Hormonal Treatment
TABLE 4 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Estrogen Treatment
TABLE 5 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Progestin Treatment
TABLE 6 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Combination Treatment
TABLE 7 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Thyroid Treatment
TABLE 8 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Parathyroid Treatment
TABLE 9 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Others Treatment
TABLE 10 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Non-Hormonal Treatment
TABLE 11 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Targeted Therapy Drugs Treatment
TABLE 12 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Antibiotics Therapy Drugs
TABLE 13 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Bisphosphonate Therapy Drugs
TABLE 14 Global Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type – Non-Hormonal Treatment, 2015–2025
TABLE 15 Global Women’s Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
TABLE 16 Global Women’s Health Market Size (US$ Mn) Forecast, by Region, 2015–2025
TABLE 17 North America Women’s Health Market Size (US$ Mn) Forecast, by Country, 2015–2025
TABLE 18 North America Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
TABLE 19 North America Women’s Health Market Size (US$ Mn) Forecast, by Hormonal Treatment, 2015–2025
TABLE 20 North America Women’s Health Market Size (US$ Mn) Forecast, by Non-hormonal Treatment, 2015–2025
TABLE 21 North America Women’s Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
TABLE 22 Europe Women’s Health Market Size (US$ Mn) Forecast, by Country, 2015–2025
TABLE 23 Europe Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
TABLE 24 Europe Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type – Hormonal Treatment, 2015–2025
TABLE 25 Europe Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type – Non-Hormonal Treatment, 2015–2025
TABLE 26 Europe Women’s Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
TABLE 27 Asia Pacific Women’s Health Market Size (US$ Mn) Forecast, by Country, 2015–2025
TABLE 28 Asia Pacific Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
TABLE 29 Asia Pacific Women’s Health Market Size (US$ Mn) Forecast, by Hormonal Treatment, 2015–2025
TABLE 30 Asia Pacific Women’s Health Market Size (US$ Mn) Forecast, by Non-hormonal Treatment, 2015–2025
TABLE 31 Asia Pacific Women’s Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
TABLE 32 Latin America Women’s Health Market Size (US$ Mn) Forecast, by Country, 2015–2025
TABLE 33 Latin America Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
TABLE 34 Latin America Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type – Hormonal Treatment, 2015–2025
TABLE 35 Latin America Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type – Non-Hormonal Treatment, 2015–2025
TABLE 36 Latin America Women’s Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
TABLE 37 Middle East & Africa Women’s Health Market Size (US$ Mn) Forecast, by Country, 2015–2025
TABLE 38 Middle East & Africa Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
TABLE 39 Middle East & Africa Women’s Health Market Size (US$ Mn) Forecast, by Hormonal Treatment, 2015–2025
TABLE 40 Middle East & Africa Women’s Health Market Size (US$ Mn) Forecast, by Non-hormonal Treatment, 2015–2025
TABLE 41 Middle East & Africa Women’s Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025

List of Figures

FIG. 1 Global Women’s Health Market Snapshot
FIG. 2 Revenue Share (2016)
FIG. 3 Key Industry Developments
FIG. 4 Porter’s Analysis
FIG. 5 Value Chain Analysis
FIG. 6 Market Value Share, by Treatment Type (2016)
FIG. 7 Market Value Share, by Disease Indication (2016)
FIG. 8 Market Value Share, by Region (2016)
FIG. 9 Global Women’s Health Market, by Treatment Type
FIG. 10 Global Women’s Health Market Value Share Analysis, by Treatment Type, 2016 and 2025
FIG. 11 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Hormonal Treatment
FIG. 12 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Estrogen Treatment
FIG. 13 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Progestin Treatment
FIG. 14 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Combination Treatment
FIG. 15 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Thyroid Treatment
FIG. 16 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Parathyroid Treatment
FIG. 17 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Others Treatment
FIG. 18 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Non-Hormonal Treatment
FIG. 19 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Targeted Therapy Drugs Treatment
FIG. 20 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Antibiotics Therapy Drugs
FIG. 21 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Bisphosphonate Therapy Drugs
FIG. 22 Global Women’s Health Market Value Share Analysis, by Disease Indication, 2016 and 2025
FIG. 23 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer
FIG. 24 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hypothyroidism
FIG. 25 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Post-Menopausal Syndrome
FIG. 26 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Osteoporosis
FIG. 27 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contraceptive
FIG. 28 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Uterine Fibroid (UF)
FIG. 29 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Urinary Tract Infection (UTI)
FIG. 30 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others
FIG. 31 Global Market Scenario
FIG. 32 Global Women’s Health Market Value Share Analysis, by Region, 2016 and 2025
FIG. 33 Global Women’s Health Market Attractiveness Analysis, by Region
FIG. 34 North America Women’s Health Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2015–2025
FIG. 35 North America Women’s Health Market Attractiveness Analysis, by Country, 2017-2025 
FIG. 36 North America Women’s Health Market Value Share Analysis, by Country, 2016 and 2025 
FIG. 37 North America Women’s Health Market Value Share Analysis, by Treatment Type, 2016 and 2025
FIG. 38 North America Women’s Health Market Value Share Analysis, by Disease Indication, 2016 and 2025
FIG. 39 North America Women’s Health Market Attractiveness Analysis, by Treatment Type, 2017-2025
FIG. 40 North America Women’s Health Market Attractiveness Analysis, by Disease Indication, 2017-2025
FIG. 41 Europe Women’s Health Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2015–2025
FIG. 42 Europe Women’s Health Market Attractiveness Analysis, by Country, 2017-2025 
FIG. 43 Europe Women’s Health Market Value Share Analysis, by Country, 2016 and 2025 
FIG. 44 Europe Women’s Health Market Value Share Analysis, by Treatment Type, 2016 and 2025
FIG. 45 Europe Women’s Health Market Value Share Analysis, by Disease Indication, 2016 and 2025
FIG. 46 Europe Women’s Health Market Attractiveness Analysis, by Treatment Type, 2017-2025
FIG. 47 Europe Women’s Health Market Attractiveness Analysis, by Disease Indication, 2017-2025
FIG. 48 Asia Pacific Women’s Health Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2015–2025
FIG. 49 Asia Pacific Women’s Health Market Attractiveness Analysis, by Country, 2017-2025 
FIG. 50 Asia Pacific Women’s Health Market Value Share Analysis, by Country, 2016 and 2025 
FIG. 51 Asia Pacific Women’s Health Market Value Share Analysis, by Treatment Type, 2016 and 2025
FIG. 52 Asia Pacific Women’s Health Market Value Share Analysis, by Disease Indication, 2016 and 2025
FIG. 53 Asia Pacific Women’s Health Market Attractiveness Analysis, by Treatment Type, 2017-2025
FIG. 54 Asia Pacific Women’s Health Market Attractiveness Analysis, by Disease Indication, 2017-2025
FIG. 55 Latin America Women’s Health Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2015–2025
FIG. 56 Latin America Women’s Health Market Attractiveness Analysis, by Country, 2017-2025 
FIG. 57 Latin America Women’s Health Market Value Share Analysis, by Country, 2016 and 2025 
FIG. 58 Latin America Women’s Health Market Value Share Analysis, by Treatment Type, 2016 and 2025
FIG. 59 Latin America Women’s Health Market Value Share Analysis, by Disease Indication, 2016 and 2025
FIG. 60 Latin America Women’s Health Market Attractiveness Analysis, by Treatment Type, 2017-2025
FIG. 61 Latin America Women’s Health Market Attractiveness Analysis, by Disease Indication, 2017-2025
FIG. 62 Middle East & Africa Women’s Health Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2015–2025
FIG. 63 Middle East & Africa Women’s Health Market Attractiveness Analysis, by Country, 2017-2025 
FIG. 64 Middle East & Africa Women’s Health Market Value Share Analysis, by Country, 2016 and 2025 
FIG. 65 Middle East & Africa Women’s Health Market Value Share Analysis, by Treatment Type, 2016 and 2025
FIG. 66 Middle East & Africa Women’s Health Market Value Share Analysis, by Disease Indication, 2016 and 2025
FIG. 67 Middle East & Africa Women’s Health Market Attractiveness Analysis, by Treatment Type, 2017-2025
FIG. 68 Middle East & Africa Women’s Health Market Attractiveness Analysis, by Disease Indication, 2017-2025
FIG. 69 Competitive Positioning, 2016
FIG. 70 Breakdown of Net Sales, by Region, 2016
FIG. 71 Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

314

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved